Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2021-04-27 Governance Information
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
《公司章程》（2021年4月修订）
Governance Information Classification · 100% confidence The document is titled "益丰大药房连锁股份有限公司 公司章程" which translates to "Yifeng Pharmacy Chain Co., Ltd. Articles of Association" or "Company Charter." The content includes detailed provisions on company organization, shareholder rights, board structure, management, financial accounting, profit distribution, audit, and procedures for shareholder meetings. It is a comprehensive governance document that sets out the internal rules and regulations of the company. There is no indication that this is an announcement, a financial report, or a meeting transcript. It is not a report publication announcement or a regulatory filing. The document is clearly a governance document detailing the company's internal rules and governance practices, which fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance content, confirming it is not a brief announcement or a certification. Therefore, the appropriate classification is CGR with high confidence.
2021-04-27 Chinese
益丰药房关于变更注册资本、经营范围及修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from the company Yifeng Pharmacy Chain Co., Ltd. regarding changes to its registered capital, business scope, and amendments to its Articles of Association. It details board meeting decisions on capital changes, share repurchases, and business scope expansions, along with specific revisions to the company's Articles of Association. The document is a formal announcement of corporate governance and capital structure changes, not a full financial report or detailed management discussion. It does not contain financial statements or earnings data. The content aligns with announcements about changes in company capital and governance documents rather than a full annual or interim report. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA), as it involves changes in registered capital and share capital adjustments.
2021-04-27 Chinese
中信证券股份有限公司对益丰大药房连锁股份有限公司2020年度募集资金存放与使用情况的专项核查报告
Audit Report / Information Classification · 100% confidence The document is titled as a "2020年度募集资金存放与使用情况的专项核查报告" which translates to a "Special Audit Report on the Deposit and Use of Raised Funds for the Year 2020". It is issued by 中信证券股份有限公司 (CITIC Securities) as the sponsor institution for 益丰大药房连锁股份有限公司 (Yifeng Pharmacy Chain Co., Ltd.). The document details the amounts raised through non-public issuance of A shares and public issuance of convertible bonds, the management and use of these funds, compliance with regulatory requirements, and audit opinions. It includes detailed tables of fund usage, bank accounts, and investment projects, as well as audit conclusions stating no misuse or irregularities. The document is a standalone audit report focusing on the verification and compliance of raised funds usage, not a full annual report or earnings release. It does not contain comprehensive financial statements or management discussion of overall company performance, but rather a specialized audit on fundraising and fund usage. Therefore, the appropriate classification is Audit Report / Information (AR). The document length (over 14,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification letter. FY 2020
2021-04-27 Chinese
益丰药房第四届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the second meeting of the fourth board of directors of Yifeng Pharmacy Chain Co., Ltd. It includes multiple agenda items such as approval of the 2020 annual reports, financial statements, audit reports, internal control reports, profit distribution plans, appointment of auditors, and other corporate governance matters. The document references the 2020 fiscal year and mentions that many of these items will be submitted to the shareholders' meeting for approval. It also includes voting results and mentions that the full reports are available on the Shanghai Stock Exchange website. The document is not the annual report itself but a board meeting resolution announcement covering multiple governance and financial reporting topics. This fits best under the category of Board/Management Information (MANG), as it primarily reports on board meeting decisions and management reports rather than the full annual report or standalone audit report. The document length (7571 characters) and detailed content support this classification rather than a brief announcement or a full report.
2021-04-27 Chinese
益丰药房关于公司及实际控制人为子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Yifeng Pharmacy Chain Co., Ltd. regarding the company and its actual controller providing joint liability guarantees for bank credit applications by its subsidiaries. It details the guarantee amounts, the subsidiaries involved, their financial status, and the approval process including board and supervisory opinions. The document is a formal disclosure of a financing-related guarantee arrangement, not a financial report or earnings release. It does not contain financial statements or detailed financial analysis but rather a specific update on capital/financing activities related to guarantees for bank credit. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2828 characters, which is consistent with an announcement rather than a full report. Hence, the classification is CAP with high confidence.
2021-04-27 Chinese
益丰药房2020年内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2020 年度内部控制评价报告' which translates to '2020 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2020. The content includes detailed descriptions of internal control scope, evaluation criteria, defect classifications, and conclusions about the effectiveness of financial and non-financial internal controls. It is a standalone report focused on internal control evaluation rather than a full annual report or financial statement. There is no indication that this is an announcement or a brief summary; the document contains substantive content about internal control evaluation. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles, including internal control evaluations. The document length is 4259 characters, which is sufficient for a detailed report but not a brief announcement. Therefore, the appropriate classification is AR with high confidence. FY 2020
2021-04-27 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.